Cargando…
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883152/ https://www.ncbi.nlm.nih.gov/pubmed/36482128 http://dx.doi.org/10.1038/s41375-022-01770-3 |
| _version_ | 1784879445697363968 |
|---|---|
| author | Locatelli, Franco Zugmaier, Gerhard Rizzari, Carmelo Morris, Joan D. Gruhn, Bernd Klingebiel, Thomas Parasole, Rosanna Linderkamp, Christin Flotho, Christian Petit, Arnaud Micalizzi, Concetta Zeng, Yi Desai, Rajendra Kormany, William N. Eckert, Cornelia Möricke, Anja Sartor, Mary Hrusak, Ondrej Peters, Christina Saha, Vaskar Vinti, Luciana von Stackelberg, Arend |
| author_facet | Locatelli, Franco Zugmaier, Gerhard Rizzari, Carmelo Morris, Joan D. Gruhn, Bernd Klingebiel, Thomas Parasole, Rosanna Linderkamp, Christin Flotho, Christian Petit, Arnaud Micalizzi, Concetta Zeng, Yi Desai, Rajendra Kormany, William N. Eckert, Cornelia Möricke, Anja Sartor, Mary Hrusak, Ondrej Peters, Christina Saha, Vaskar Vinti, Luciana von Stackelberg, Arend |
| author_sort | Locatelli, Franco |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9883152 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98831522023-01-29 Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL Locatelli, Franco Zugmaier, Gerhard Rizzari, Carmelo Morris, Joan D. Gruhn, Bernd Klingebiel, Thomas Parasole, Rosanna Linderkamp, Christin Flotho, Christian Petit, Arnaud Micalizzi, Concetta Zeng, Yi Desai, Rajendra Kormany, William N. Eckert, Cornelia Möricke, Anja Sartor, Mary Hrusak, Ondrej Peters, Christina Saha, Vaskar Vinti, Luciana von Stackelberg, Arend Leukemia Letter Nature Publishing Group UK 2022-12-08 2023 /pmc/articles/PMC9883152/ /pubmed/36482128 http://dx.doi.org/10.1038/s41375-022-01770-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Locatelli, Franco Zugmaier, Gerhard Rizzari, Carmelo Morris, Joan D. Gruhn, Bernd Klingebiel, Thomas Parasole, Rosanna Linderkamp, Christin Flotho, Christian Petit, Arnaud Micalizzi, Concetta Zeng, Yi Desai, Rajendra Kormany, William N. Eckert, Cornelia Möricke, Anja Sartor, Mary Hrusak, Ondrej Peters, Christina Saha, Vaskar Vinti, Luciana von Stackelberg, Arend Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL |
| title | Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL |
| title_full | Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL |
| title_fullStr | Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL |
| title_full_unstemmed | Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL |
| title_short | Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL |
| title_sort | improved survival and mrd remission with blinatumomab vs. chemotherapy in children with first high-risk relapse b-all |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883152/ https://www.ncbi.nlm.nih.gov/pubmed/36482128 http://dx.doi.org/10.1038/s41375-022-01770-3 |
| work_keys_str_mv | AT locatellifranco improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT zugmaiergerhard improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT rizzaricarmelo improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT morrisjoand improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT gruhnbernd improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT klingebielthomas improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT parasolerosanna improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT linderkampchristin improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT flothochristian improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT petitarnaud improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT micalizziconcetta improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT zengyi improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT desairajendra improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT kormanywilliamn improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT eckertcornelia improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT morickeanja improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT sartormary improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT hrusakondrej improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT peterschristina improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT sahavaskar improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT vintiluciana improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball AT vonstackelbergarend improvedsurvivalandmrdremissionwithblinatumomabvschemotherapyinchildrenwithfirsthighriskrelapseball |